BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33412634)

  • 21. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.
    Kinslow CJ; Bruce SS; Rae AI; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sonabend AM; Wang TJC
    J Neurooncol; 2018 May; 138(1):173-182. PubMed ID: 29427152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
    Furst T; Hoffman H; Chin LS
    J Neurosurg Sci; 2024 Feb; 68(1):44-50. PubMed ID: 31601065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
    Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
    [No Abstract]   [Full Text] [Related]  

  • 26. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
    Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
    BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.
    Schellekes N; Barbotti A; Abramov Y; Sitt R; Di Meco F; Ram Z; Grossman R
    J Neurosurg; 2021 Feb; 135(4):1016-1025. PubMed ID: 33636699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cleveland Clinic experience with primary central nervous system lymphoma.
    Xie H; Ahluwalia MS; Peereboom DM
    Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the Clinical Characteristics and Prognostic Factors of 31 Cases of Primary Central Nervous System Lymphoma].
    Fu L; Chen L; Wei N; Huang DY; Shen J; Wang JS; Wang YN; Cui H; Yang LZ; Wang Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1061-5. PubMed ID: 27531775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.
    Abdelsalam M; El-Husseiny G; Akhtar S; Khafaga Y; Al-Shabana M; AlHusaini H; El Weshi A; Rahal M; Maghfoor I
    Hematol Oncol Stem Cell Ther; 2010; 3(3):128-34. PubMed ID: 20890070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
    Kim YJ; Lee DJ; Park CK; Kim IA
    Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
    Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
    J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; QuiƱones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival among patients with primary central nervous system lymphoma, 1973-2004.
    Norden AD; Drappatz J; Wen PY; Claus EB
    J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
    Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
    World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Craniotomy and Survival for Primary Central Nervous System Lymphoma.
    Rae AI; Mehta A; Cloney M; Kinslow CJ; Wang TJC; Bhagat G; Canoll PD; Zanazzi GJ; Sisti MB; Sheth SA; Connolly ES; McKhann GM; Bruce JN; Iwamoto FM; Sonabend AM
    Neurosurgery; 2019 Apr; 84(4):935-944. PubMed ID: 29660011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical prognostic factors for central neurocytoma and subgroup analysis of different treatment measures: A SEER database-based retrospective analysis from 2003 to 2019.
    Zhang Z; Yu J; Zhang C; Pang X; Wei Y; Lv Q; Chen H; Jin X; Zhan R
    Front Oncol; 2022; 12():1014506. PubMed ID: 36686752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
    Alattar AA; Carroll KT; Bryant AK; Hirshman B; Joshi R; Carter BS; Harismendy O; Chen CC
    World Neurosurg; 2019 Jan; 121():e411-e418. PubMed ID: 30266697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.